← Leaderboards
Sujee Jeyapalina
Va Salt Lake City Healthcare System
$211,750
Attributed
$423,500
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $423.5K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$423,500 · 1
VA$0 · 1
By mechanism
R21$423,500 · 1
I01$0 · 1
Top collaborators
- Jill E Shea1 shared
Most similar at Va Salt Lake City Healthcare System
Same institution · by research overlap
- Sarina Kay Sinclair$0
- Kent N. Bachus$727,261
- Erik Kubiak$0
Others in their field
Other Emerging Leaders on “In Vitro”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
- Tony Moody · Duke University$34,777,314
Research focus
In VitroPropertyHealingInfectionOperative Surgical ProceduresPreventEfficacy TestingFluorapatiteHigh Temperature Of Physical ObjectImplantIn VivoApatitesPhenotypeAutopsyCrystallinityDesignFamily SuidaeBone TissueDefectBiomaterial CompatibilityBoneCellsAdhesionsRattus
Grant awards (6)
Surface Induced Epithelial Differentiation Improves Percutaneous Device Longevity$0
I01 · FY2025 · VA · contact PI
Surface Induced Epithelial Differentiation Improves Percutaneous Device Longevity$0
I01 · FY2024 · VA · contact PI
Determining the Efficacy of a Novel Apatite-Based Antimicrobial Bone Scaffold for Craniofacial Surgical Applications$423,500
R21 · FY2023 · DE · contact PI
Surface Induced Epithelial Differentiation Improves Percutaneous Device Longevity$0
I01 · FY2023 · VA · contact PI
Surface Induced Epithelial Differentiation Improves Percutaneous Device Longevity$0
I01 · FY2022 · VA · contact PI
Surface Induced Epithelial Differentiation Improves Percutaneous Device Longevity$0
I01 · FY2021 · VA · contact PI